|
Mr. Rodriguez brings to Neurochem almost 15 years experience with private and public companies in corporate finance. He has spent more than nine years in senior financial positions with high-growth biopharmaceutical companies and has a track record of successful financial transactions in companies listed on the TSX and NASDAQ. Most recently Mr. Rodriguez was Vice President and CFO of Galileo Genomics Inc. and earlier served as Corporate Controller and Director of Finance for Phoenix International Life Sciences Inc. There he played a key role in several public equity issues and debt financings and contributed significantly to the growth of the company which, during his tenure, had revenues that rose from CAN$50 million to CAN$350 million, with operations in 16 countries. Mr. Rodriguez is a Chartered Accountant, a graduate of McGill University and a Certified Public Accountant. He has received several prizes and awards in commerce, taxation and for academic performance from McGill University and Ernst & Young LLP where he began his career. | 